全球范围内，大多数病人无法获得临终关怀服务。评估电话监护——“远程临终关怀”在为肯尼亚西部一个三级综合医院出院患者提供症状管理方面的可行性。入选标准包括接受止痛治疗且不再适合进行化疗放疗的成年癌症患者。30名患者被纳入每周监测计划，评估身体症状以及病人和照顾者的困扰。参与者还可以使用24小时热线。症状评估包括18个问题，其中8个来自非洲姑息治疗成果量表。参与者被随访8周，直到死亡或入院治疗。 主要目标是每周通话的参与度，我们达到了100%的参与度。次要目标是使用“舒适工具包”，其中包含6种药物的30剂量。大多数患者使用了提供的一种或多种药物，其中比司通、扑热息痛和奥美拉唑的使用率较高。虽然每周通话中有12%以及热线中有24%的通话导致药物改变，但参与者仍然表达了担心，尽管在随访期间可以随时使用吗啡，疼痛程度只有轻微下降。家庭在提供护理和获取信息方面的信心仍然很高。在观察了八周之后，8名参与者仍然健在，10名患者在家去世，12名患者被送往住院设施。 远程临终关怀的患者和家属参与是可行的，可能会为无法获得居家临终关怀的患者提供一种过渡性解决方案。版权所有©2023 Elsevier Inc. 发表。

Worldwide, most patients lack access to hospice services.Assess the feasibility of telephone monitoring (Telehospice) in providing symptom management for patients discharged from a tertiary care hospital in Western Kenya.Inclusion criteria included adults with cancer no longer eligible for chemo-radiation and receiving opioid therapy. Thirty patients were enrolled in a weekly monitoring program assessing physical symptoms and patient and caregiver distress. The participants also had access to a 24-hour hotline. Symptom assessment included 18 questions with 8 from the African Palliative Outcome Scale. Participants were followed for 8 weeks or until death or admission to an inpatient hospital or hospice.The primary objective was participation in weekly calls, and we obtained 100% participation. A secondary objective was the use of "comfort kits" which contained 30 doses of six medications. Most patients utilized one or more of the provided medications, with high usage of bisacodyl, paracetamol, and omeprazole. While 12% of weekly calls and 24% of hotline calls led to medication changes, participants continued to express worry and there was only a modest decrease in pain scores despite having morphine available throughout the follow-up period. Family confidence in providing care and access to information remained high. At the end of the eight-weeks of observation, 8 participants were alive, 10 died at home, and 12 were admitted to an in-patient facility.Patient and family participation in Telehospice is feasible and may provide an interim solution to managing end-of-life patients who lack access to home hospice.Copyright © 2023. Published by Elsevier Inc.